Neuroinflammation, COX-2, and ALS—a dual role?

[1]  G. Pasinetti,et al.  A therapeutic role for cyclooxygenase‐2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[2]  Alain Lilienbaum,et al.  From Calcium to NF-κB Signaling Pathways in Neurons , 2003, Molecular and Cellular Biology.

[3]  J. Rothstein,et al.  Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS , 2002, Annals of neurology.

[4]  P. Mcgeer,et al.  Inflammatory processes in amyotrophic lateral sclerosis , 2002, Muscle & nerve.

[5]  L. Marnett,et al.  Selective oxygenation of N-arachidonylglycine by cyclooxygenase-2. , 2002, Biochemical and biophysical research communications.

[6]  E. Baik,et al.  Effects of peroxisome proliferator-activated receptor agonists on LPS-induced neuronal death in mixed cortical neurons: associated with iNOS and COX-2 , 2002, Brain Research.

[7]  J. Schwab,et al.  Persistent accumulation of cyclooxygenase-1-expressing microglial cells and macrophages and transient upregulation by endothelium in human brain injury. , 2002, Journal of neurosurgery.

[8]  G. Pasinetti,et al.  Role of cyclooxygenase-2 in neuronal cell cycle activity and glutamate-mediated excitotoxicity. , 2002, The Journal of pharmacology and experimental therapeutics.

[9]  L. Deecke,et al.  Increased levels of the pro-inflammatory prostaglandin PGE2 in CSF from ALS patients , 2002, Neurology.

[10]  H. Ball,et al.  Prostaglandin E2 inhibits calcium current in two sub‐populations of acutely isolated mouse trigeminal sensory neurons , 2002, The Journal of physiology.

[11]  T. Takadera,et al.  Prostaglandin E2 induces caspase-dependent apoptosis in rat cortical cells , 2002, Neuroscience Letters.

[12]  Jeffrey D. Rothstein,et al.  From charcot to lou gehrig: deciphering selective motor neuron death in als , 2001, Nature Reviews Neuroscience.

[13]  A. Baldwin,et al.  Positive and negative regulation of NF-kappaB by COX-2: roles of different prostaglandins. , 2001, The Journal of biological chemistry.

[14]  L. Ragolia,et al.  Prostaglandin D2 synthase induces apoptosis in PC12 neuronal cells , 2001, Neuroreport.

[15]  P. Isakson,et al.  The Acute Antihyperalgesic Action of Nonsteroidal, Anti-Inflammatory Drugs and Release of Spinal Prostaglandin E2 Is Mediated by the Inhibition of Constitutive Spinal Cyclooxygenase-2 (COX-2) but not COX-1 , 2001, The Journal of Neuroscience.

[16]  L. Marnett,et al.  Amino Acid Determinants in Cyclooxygenase-2 Oxygenation of the Endocannabinoid 2-Arachidonylglycerol* , 2001, The Journal of Biological Chemistry.

[17]  K M Heilman,et al.  Anomalous anatomy of speech–language areas in adults with persistent developmental stuttering , 2001, Neurology.

[18]  D. Allan Butterfield,et al.  Brain protein oxidation in age-related neurodegenerative disorders that are associated with aggregated proteins , 2001, Mechanisms of Ageing and Development.

[19]  S. Grösch,et al.  Celecoxib loses its anti‐inflammatory efficacy at high doses through activation of NF‐κB , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[20]  C. Glass,et al.  Cyclopentenone prostaglandins: New insights on biological activities and cellular targets , 2001, Medicinal research reviews.

[21]  T. Chase,et al.  Prostaglandin A(1) protects striatal neurons against excitotoxic injury in rat striatum. , 2001, The Journal of pharmacology and experimental therapeutics.

[22]  C. Cotman,et al.  15-Deoxy-Δ12,14-prostaglandin J2, a specific ligand for peroxisome proliferator-activated receptor-γ, induces neuronal apoptosis , 2001 .

[23]  G. Rosoklija,et al.  Increased expression of the pro‐inflammatory enzyme cyclooxygenase‐2 in amyotrophic lateral sclerosis , 2001, Annals of neurology.

[24]  M. Ross,et al.  Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[25]  J. Rothstein,et al.  Inhibition of cyclooxygenase‐2 protects motor neurons in an organotypic model of amyotrophic lateral sclerosis , 2000, Annals of neurology.

[26]  C. Hoffmann.  COX-2 in brain and spinal cord implications for therapeutic use. , 2000, Current medicinal chemistry.

[27]  E. Brown,et al.  Expression of peroxisome proliferator‐activated receptors (PPARS) in human astrocytic cells: PPARγ agonists as inducers of apoptosis , 2000 .

[28]  C. Plata-salamán,et al.  Inflammation and Alzheimer’s disease , 2000, Neurobiology of Aging.

[29]  S. L. Gray,et al.  Does the insulin-like growth factor system interact with prostaglandins and proinflammatory cytokines during neurodegeneration? , 2000, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[30]  T. Uliasz,et al.  Cyclooxygenase-2 contributes to N-methyl-D-aspartate-mediated neuronal cell death in primary cortical cell culture. , 2000, The Journal of pharmacology and experimental therapeutics.

[31]  A. Araque,et al.  Prostaglandin E(2) stimulates glutamate receptor-dependent astrocyte neuromodulation in cultured hippocampal cells. , 1999, Journal of neurobiology.

[32]  J. Rogers,et al.  Cyclooxygenase-1 in human Alzheimer and control brain: quantitative analysis of expression by microglia and CA3 hippocampal neurons. , 1999, Journal of neuropathology and experimental neurology.

[33]  R. Bucala,et al.  A receptor for advanced glycosylation endproducts (AGEs) is colocalized with neurofilament-bound AGEs and SOD1 in motoneurons of ALS: immunohistochemical study , 1999, Journal of the Neurological Sciences.

[34]  G. Pasinetti,et al.  Potentiation of excitotoxicity in transgenic mice overexpressing neuronal cyclooxygenase-2. , 1999, The American journal of pathology.

[35]  Yasuyoshi Watanabe,et al.  A Novel Subtype of Prostacyclin Receptor in the Central Nervous System , 1999, Journal of Neurochemistry.

[36]  D. Gilroy,et al.  Inducible cyclooxygenase may have anti-inflammatory properties , 1999, Nature Medicine.

[37]  Satoshi Horie,et al.  Prostaglandin E1 Transported into Cells Blocks the Apoptotic Signals Induced by Nerve Growth Factor Deprivation , 1999, Journal of Neurochemistry.

[38]  P. Leigh,et al.  Cells from individuals with SOD-1 associated familial amyotrophic lateral sclerosis do not have an increased susceptibility to radiation-induced free radical production or DNA damage , 1999, Journal of the Neurological Sciences.

[39]  Olivier Curet,et al.  Beneficial Effects of Lysine Acetylsalicylate, a Soluble Salt of Aspirin, on Motor Performance in a Transgenic Model of Amyotrophic Lateral Sclerosis , 1999, Experimental Neurology.

[40]  A. Paetau,et al.  Cyclooxygenase‐2 is induced globally in infarcted human brain , 1998, Annals of neurology.

[41]  L. Horrocks,et al.  A light and electron microscopic study of cytoplasmic phospholipase A2 and cyclooxygenase-2 in the hippocampus after kainate lesions , 1998, Brain Research.

[42]  Tullio Pozzan,et al.  Prostaglandins stimulate calcium-dependent glutamate release in astrocytes , 1998, Nature.

[43]  G. Levi,et al.  Reorientation of prostanoid production accompanies “activation” of adult microglial cells in culture , 1997, Journal of neuroscience research.

[44]  P. Aisen,et al.  Maturational Regulation and Regional Induction of Cyclooxygenase-2 in Rat Brain: Implications for Alzheimer's Disease , 1997, Experimental Neurology.

[45]  P. Gebicke-haerter,et al.  Expression and regulation of cyclooxygenase-2 in rat microglia. , 1997, European journal of biochemistry.

[46]  M. Runge,et al.  Hypoxia Induces Cyclooxygenase-2 via the NF-κB p65 Transcription Factor in Human Vascular Endothelial Cells* , 1997, The Journal of Biological Chemistry.

[47]  M. Harrison,et al.  Cyclo-oxygenase-2 Messenger RNA Induction in Focal Cerebral Ischemia , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[48]  Julia W. Chang,et al.  Prostaglandin G/H synthase-2 (cyclooxygenase-2) mRNA expression is decreased in Alzheimer's disease , 1996, Neurobiology of Aging.

[49]  D. Schiffer,et al.  Reactive astrogliosis of the spinal cord in amyotrophic lateral sclerosis , 1996, Journal of the Neurological Sciences.

[50]  G. Kreutzberg.  Microglia: a sensor for pathological events in the CNS , 1996, Trends in Neurosciences.

[51]  E. Bonmassar,et al.  Prostaglandin E2 induces apoptosis in resting immature and mature human lymphocytes: a c-Myc-dependent and Bcl-2-independent associated pathway. , 1996, The Journal of pharmacology and experimental therapeutics.

[52]  Julia W. Chang,et al.  Interleukin‐1β Induces Prostaglandin G/H Synthase‐2 (Cyclooxygenase‐2) in Primary Murine Astrocyte Cultures , 1996, Journal of neurochemistry.

[53]  P. Worley,et al.  COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[54]  S. Thanos,et al.  The concept of microglia in relation to central nervous system disease and regeneration , 1996, Progress in Neurobiology.

[55]  J. Crapo,et al.  Requirement for Superoxide in Excitotoxic Cell Death , 1996, Neuron.

[56]  J. de Belleroche,et al.  Cyclooxygenase‐2 Induction in Cerebral Cortex: An Intracellular Response to Synaptic Excitation , 1996, Journal of neurochemistry.

[57]  G. Levi,et al.  Induction of Prostanoid Biosynthesis by Bacterial Lipopolysaccharide and Isoproterenol in Rat Microglial Cultures , 1995, Journal of neurochemistry.

[58]  S. Graham,et al.  Expression of cyclo-oxygenase 2 in rat brain following kainate treatment. , 1995, NeuroReport.

[59]  S. Narumiya,et al.  Prostaglandin E2 protects cultured cortical neurons against N-methyl-d-aspartate receptor-mediated glutamate cytotoxicity , 1994, Brain Research.

[60]  C. Bonne,et al.  Protection by prostaglandins from glutamate toxicity in cortical neurons , 1994, Neurochemistry International.

[61]  Carol A. Barnes,et al.  Expression of a mitogen-inducible cyclooxygenase in brain neurons: Regulation by synaptic activity and glucocorticoids , 1993, Neuron.

[62]  Y. Yoshihara,et al.  Expression of prostaglandin endoperoxide synthase in rat brain. , 1993, Brain research. Molecular brain research.

[63]  J. Hammond,et al.  Divergent actions of prostaglandins-E2 and -F2 alpha on the regulation of insulin-like growth factor-binding protein-3 in luteinized granulosa cells. , 1993, Endocrinology.

[64]  P. Mcgeer,et al.  Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. , 1992, The American journal of pathology.

[65]  O. Hayaishi.  Molecular mechanisms of sleep‐wake regulation: roles of prostaglandins D2 and E2 , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[66]  D. Troost,et al.  Immunohistochemical characterization of the inflammatory infiltrate in amyotrophic lateral sclerosis , 1990, Neuropathology and applied neurobiology.

[67]  P. Kushner,et al.  Major histocompatibility complex antigen expression in the affected tissues in amyotrophic lateral sclerosis , 1990, Annals of neurology.

[68]  S. Appel,et al.  Experimental autoimmune motoneuron disease , 1989, Annals of neurology.

[69]  H. Hartung,et al.  Recombinant interleukin-1β stimulates eicosanoid production in rat primary culture astrocytes , 1989, Brain Research.

[70]  A. Arimura,et al.  Interleukin-1 beta increases prostaglandin E2 in rat astrocyte cultures: modulatory effect of neuropeptides. , 1989, Endocrinology.

[71]  P. Gebicke-haerter,et al.  Lipopolysaccharide-free conditions in primary astrocyte cultures allow growth and isolation of microglial cells , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[72]  N. Carlson.  Neuroprotection of cultured cortical neurons mediated by the cyclooxygenase‐2 inhibitor APHS can be reversed by a prostanoid , 2003, Journal of neuroscience research.

[73]  C. Svensson,et al.  The spinal phospholipase-cyclooxygenase-prostanoid cascade in nociceptive processing. , 2002, Annual review of pharmacology and toxicology.

[74]  Wan-Wan Lin,et al.  Effects of cannabinoids on LPS‐stimulated inflammatory mediator release from macrophages: Involvement of eicosanoids , 2001, Journal of cellular biochemistry.

[75]  M. O’Banion,et al.  Cyclooxygenase-2: molecular biology, pharmacology, and neurobiology. , 1999, Critical reviews in neurobiology.

[76]  A. Baldwin,et al.  THE NF-κB AND IκB PROTEINS: New Discoveries and Insights , 1996 .

[77]  K. Wu,et al.  Role of endothelium in thrombosis and hemostasis. , 1996, Annual review of medicine.

[78]  J. Tajti,et al.  Lymphocytic infiltrates in the spinal cord in amyotrophic lateral sclerosis. , 1993, Archives of neurology.

[79]  Lee Goldman,et al.  Cecil Textbook of Medicine , 1985 .